Press Releases ProKidney Corp.

Equities

PROK

KYG7S53R1049

Real-time Estimate Cboe BZX Other stock markets 01:06:18 2024-05-17 pm EDT			5-day change	1st Jan Change
4.015 ^USD	+2.42%		+50.19%	+120.22%

May. 10	ProKidney Q1 Loss Unchanged From Year Earlier	MT
May. 10	ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProKidney Reports Business Updates and First Quarter 2024 Financial Results	May. 13	AQ
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	May. 10	AQ
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	Mar. 25	AQ
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights	Mar. 21	AQ
ProKidney to Participate in Jefferies Biotech on the Bay Summit	Feb. 29	AQ
Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments, Companies 2023 \| Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, Prokidney, and others.	Dec. 05	AQ
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer	Nov. 30	AQ
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference	Nov. 21	AQ
ProKidney Reports Third Quarter Financial Results	Nov. 14	AQ
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates	Nov. 13	AQ
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023	23-10-31	AQ
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023	23-10-30	AQ
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference	23-09-05	AQ
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights	23-08-10	AQ
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC	23-07-18	AQ
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization	23-07-17	AQ
PROKIDNEY CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-06-16	AQ
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC	23-06-13	AQ
ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference	23-06-01	AQ
ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights	23-05-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ProKidney Corp.

Equities

PROK

KYG7S53R1049

Press Releases

Filters